Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.
Press releases published on September 16, 2025
Spectral Medical Announces Publication of EDEN Observational Study
TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today highlighted newly published findings in Critical …
Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap
MALVERN, Pa., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) …
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
MIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor today announced activation of two …
AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th
PHOENIX and LONDON, Sept. 16, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today announced that Wendy Blosser, CEO, will present …
Hop Valley Brewing and Oregon Athletics Announce the Launch of Dang Green IPA, the First Official Craft Beer for the Oregon Ducks
EUGENE, Ore., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Hop Valley Brewing Co. (“Hop Valley Brewing” or “Hop Valley”), a trailblazer in the craft brewing industry and brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a leading global lifestyle and …
Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update
In a rodent model of T2D, icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with preservation of lean mass, outperforming the group given semaglutide alone. U.S. Food and Drug Administration ( …
Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System to US FDA for 510(k) Clearance
US FDA 510(k) Submission Follows the Successful Validation Testing with KOLs FDA 510(k) Clearance Anticipated During H1 2026 and Company Preparing for US Commercial Launch following Clearance Coronary Intravascular Imaging Market Expected to Grow to over $ …
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), a leading provider of innovative laboratory equipment, is pleased to announce the expansion of its distribution agreement …
Verano Broadens Florida Retail Footprint to 82 Dispensaries with the Opening of MÜV Crystal River
MÜV Crystal River is located at 941 NE US Hwy 19, a busy thoroughfare with an average daily traffic count of 23,000 vehicles1 The dispensary is Verano’s first MÜV location in Florida’s Citrus County, a growing region with over 150,000 residents2 Verano’s …
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that …
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
Provides Patent Protection in Europe Through at Least December 2040 Further IP Protection for TNX-103 (Oral Levosimendan) and Other Drug Formulations, and its Active Metabolites, in PH-HFpEF Also Provides Patent Protection for Wide Range of Levosimendan …
Immuneering Appoints Dr. Thomas Schall as Chairman of the Board
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced the appointment of Thomas J. Schall, Ph.D., to Chairman of the Board of …
Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that an issue of the book series Methods in Molecular Biology dedicated to studies of the catastrophic genome rearrangement known as chromoanagenesis was …
Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
Posters support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population LONDON and RALEIGH, N.C., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona” or the “Company”), a …
Strengthening Rabies Defence in Canada: CAHI Announces 2025 World Rabies Day Webinar
OTTAWA, Ontario, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is proud to continue its tradition of hosting a webinar in recognition of World Rabies Day. This year’s event, taking place on Friday, September 26, 2025, will …
QuestionPro and Day One Strategy Release 2025 Clinician AI Readiness Survey
AUSTIN, Texas, Sept. 16, 2025 (GLOBE NEWSWIRE) -- QuestionPro, in partnership with healthcare insight and strategy consultancy Day One Strategy, today announced the release of its latest industry report: The 2025 Clinician AI Readiness Survey. Based on …
Renforcer la lutte contre la rage au Canada : l’ICSA annonce son webinaire à l’occasion de la Journée mondiale contre la rage 2025
OTTAWA, Ontario, 16 sept. 2025 (GLOBE NEWSWIRE) -- L’Institut canadien de santé animale (ICSA) est fier de poursuivre sa tradition en organisant un webinaire à l’occasion de la Journée mondiale contre la rage. L’événement de cette année, qui aura lieu le …
ITM to Present COMPETE Dosimetry Data and Host Satellite Symposium at EANM 2025
Garching / Munich, Germany, September 16, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will unveil dosimetry data from its recent Phase 3 COMPETE trial in an oral presentation at …